Allocation of R&D investments in pharmaceutical industry by function 2017

This statistic displays the pharmaceutical industry's research and development investment allocation by select functions in 2017. The pharmaceutical industry spent 15.6 percent of research and development investments during pre-human or pre-clinical stages.

Allocation of research and development investments in pharmaceutical industry in 2017, by function

Percentage of R&D investments
Pre-human/pre-clinical15.6%
Clinical trials50.2%
Phase I*8.7%
Phase II*11.6%
Phase III*29.9%
Approval3.9%
Pharmacovigiliance (Phase IV)11.4%
Uncategorized18.8%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2019

Region

Worldwide

Survey time period

2017

Supplementary notes

EFPIA: European Federation of Pharmaceutical Industries and Associations
* Phase I to III are part of clinical trials.
Note: PhRMA, Annual Membership Survey 2018 (percentages calculated from 2017 data; total values may be affected by rounding).

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Oncology"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.